With the future looking forward to utilizing the therapeutic powers of rnai, this new therapy has to be made personalized. After all we are talking about silencing genes. Different people have different genetic make ups and hence these interferences will have to designed on an indivisual basis especially when we talking about diseases caused by multiple gene interactions.
Personalized medicine- a hot topic in current healthcare debate- has the following isues associated with it. First we have the economic aspect- is it going to be worth all the time and effort? Is it going to be affordable? Second- what market are we catering to? Third- will insurance companies cover this new approach? The answers to these questions lie as much in the future as the therapy itself. We cannot tell. What we do know is that it s definitely going to be expensive, affordable by only a few and insurance might cover it. However when one analyses the situation, the potential benefits greatly outweigh the risks involved. "RNAi has an unbelievable potential to manage genetic diseases and treat them," said Steven Dowdy, PhD, Howard Hughes Medical Institute Investigator and professor of cellular and molecular medicine at UC San Diego School of Medicine. "While there's still a long way to go, we have successfully developed a technology that allows for siRNA drug delivery into the entire population of cells, both primary and tumor-causing, without being toxic to the cells."
Especially in the case of genetic disorders, where nothing works better than personalized medicine, as of now, Rnai is all we have the table. To view more articles on personalized medicine and its future check out the link below:
http://www.personalizedmedicine.com/articles.php
No comments:
Post a Comment